US officials sought a "groundbreaking" injunction against Indian drug giant Ranbaxy on Wednesday, saying the maker of the first generic version of cholesterol-lowering Lipitor has failed to meet US safety guidelines.
Jan 26, 2012
0
0
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.
Feb 9, 2012
1
0
(HealthDay) -- The first generic versions of the once-monthly osteoporosis drug Boniva (ibandronate) have been approved by the U.S. Food and Drug Administration.
Mar 19, 2012
0
0
U.S. hospitals fed up with shortages of critical medicines—mostly generic drugs that aren't profitable—have banded together.
Jan 26, 2020
0
9
(HealthDay)—The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.
Dec 28, 2018
0
0
European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU's executive confirmed on Monday.
Jul 27, 2015
0
31
Prescription drug costs represent nearly 10 percent of total health care expenses for Americans, pushing the issue to the forefront of national health care policy conversations. With rising costs an ongoing concern, a study ...
Nov 23, 2021
0
32
(HealthDay)—Market forces are dramatically driving up the cost of some generic drugs, prompting U.S. investigations into the pricing of what should be cheap alternatives to brand-name medications.
Nov 13, 2014
1
0
Anyone keeping tabs on how much they spend at the pharmacy knows that drug costs are rising, but what exactly is driving prices upward is often a mystery.
Jan 11, 2019
0
1
When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug, according to a study ...
Feb 11, 2015
0
4
